Literature DB >> 22152403

Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.

Wendy M Troxel1, David J Kupfer, Charles F Reynolds, Ellen Frank, Michael E Thase, Jean M Miewald, Daniel J Buysse.   

Abstract

OBJECTIVE: Insomnia and objectively measured sleep disturbances predict poor treatment outcomes in patients with major depressive disorder (MDD). However, prior research has utilized individual clinical trials with relatively small sample sizes and has focused on insomnia symptoms or objective measures, but not both. The present study is a secondary analysis that examines the degree to which insomnia, objective sleep disturbances, or their combination predicts depression remission following pharmacotherapy and/or psychotherapy treatment.
METHOD: Participants were 711 depressed (DSM criteria) patients drawn from 6 clinical trials. Remission status, defined as a score of ≤ 7 on the Hamilton Depression Rating Scale (HDRS) over 2 consecutive months, served as the primary outcome. Insomnia was assessed via the 3 sleep items on the HDRS. Objectively measured short sleep duration (total sleep time ≤ 6 hours) and prolonged sleep latency (> 30 minutes) or wakefulness after sleep onset (> 30 minutes) were derived from in-laboratory polysomnographic sleep studies. Logistic regression predicted the odds of nonremission according to insomnia, each of the objective sleep disturbances, or their combination, after adjusting for age, sex, treatment modality, and baseline depressive symptoms.
RESULTS: Prolonged sleep latency alone (OR = 3.53; 95% CI, 1.28-9.73) or in combination with insomnia (OR = 2.11; 95% CI, 1.13-3.95) predicted increased risk of nonremission. In addition, insomnia and sleep duration individually and in combination were each associated with a significantly increased risk of nonremission (P values < .05).
CONCLUSIONS: Findings suggest that objectively measured prolonged sleep latency and short sleep duration independently or in conjunction with insomnia are risk factors for poor depression treatment outcome. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22152403      PMCID: PMC3310298          DOI: 10.4088/JCP.11m07184

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  50 in total

Review 1.  Recommendations for a standard research assessment of insomnia.

Authors:  Daniel J Buysse; Sonia Ancoli-Israel; Jack D Edinger; Kenneth L Lichstein; Charles M Morin
Journal:  Sleep       Date:  2006-09       Impact factor: 5.849

2.  Insomnia as a risk factor for onset of depression in the elderly.

Authors:  Michael L Perlis; Leisha J Smith; Jeffrey M Lyness; Sara R Matteson; Wil R Pigeon; Carla R Jungquist; Xin Tu
Journal:  Behav Sleep Med       Date:  2006       Impact factor: 2.964

3.  Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study.

Authors:  Carmen Andreescu; Eric J Lenze; Mary Amanda Dew; Amy E Begley; Benoit H Mulsant; Alexandre Y Dombrovski; Bruce G Pollock; Jacqueline Stack; Mark D Miller; Charles F Reynolds
Journal:  Br J Psychiatry       Date:  2007-04       Impact factor: 9.319

4.  Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?

Authors:  J D Edinger; A I Fins; D M Glenn; R J Sullivan; L A Bastian; G R Marsh; D Dailey; T V Hope; M Young; E Shaw; D Vasilas
Journal:  J Consult Clin Psychol       Date:  2000-08

5.  Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression.

Authors:  Ellen Frank; David J Kupfer; Daniel J Buysse; Holly A Swartz; Paul A Pilkonis; Patricia R Houck; Paola Rucci; Danielle M Novick; Victoria J Grochocinski; Deborah M Stapf
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

6.  Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?

Authors:  Wilfred R Pigeon; Mark Hegel; Jürgen Unützer; Ming-Yu Fan; Michael J Sateia; Jeffrey M Lyness; Cindy Phillips; Michael L Perlis
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

7.  Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?

Authors:  Alexandre Y Dombrovski; Jill M Cyranowski; Benoit H Mulsant; Patricia R Houck; Daniel J Buysse; Carmen Andreescu; Michael E Thase; Alan G Mallinger; Ellen Frank
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

8.  Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.

Authors:  Viola Vaccarino; B Delia Johnson; David S Sheps; Steven E Reis; Sheryl F Kelsey; Vera Bittner; Thomas Rutledge; Leslee J Shaw; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

9.  Insomnia with objective short sleep duration is associated with a high risk for hypertension.

Authors:  Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

10.  Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study.

Authors:  Alexandros N Vgontzas; Duanping Liao; Slobodanka Pejovic; Susan Calhoun; Maria Karataraki; Edward O Bixler
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 19.112

View more
  50 in total

1.  Objective measures are useful in subtyping chronic insomnia.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

2.  Mood disorders: the dark night.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2013-05-23       Impact factor: 49.962

3.  Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults.

Authors:  Eun Lee; Hyong Jin Cho; Richard Olmstead; Myron J Levin; Michael N Oxman; Michael R Irwin
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

4.  Transcriptional Signatures of Sleep Duration Discordance in Monozygotic Twins.

Authors:  N F Watson; D Buchwald; J J Delrow; W A Altemeier; M V Vitiello; A I Pack; M Bamshad; C Noonan; S A Gharib
Journal:  Sleep       Date:  2017-01-01       Impact factor: 5.849

5.  Sleep in the Military: Promoting Healthy Sleep Among U.S. Servicemembers.

Authors:  Wendy M Troxel; Regina A Shih; Eric R Pedersen; Lily Geyer; Michael P Fisher; Beth Ann Griffin; Ann C Haas; Jeremy Kurz; Paul S Steinberg
Journal:  Rand Health Q       Date:  2015-11-30

Review 6.  Mapping Movement: Applying Motion Measurement Technologies to the Psychiatric Care of Older Adults.

Authors:  Stephanie Collier; Patrick Monette; Katherine Hobbs; Edward Tabasky; Brent P Forester; Ipsit V Vahia
Journal:  Curr Psychiatry Rep       Date:  2018-07-24       Impact factor: 5.285

Review 7.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

8.  Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.

Authors:  Sharon C Sung; Stephen R Wisniewski; James F Luther; Madhukar H Trivedi; A John Rush
Journal:  J Affect Disord       Date:  2014-11-22       Impact factor: 4.839

9.  Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.

Authors:  Stephen F Smagula; Meryl A Butters; Stewart J Anderson; Eric J Lenze; Mary Amanda Dew; Benoit H Mulsant; Francis E Lotrich; Howard Aizenstein; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2015-10       Impact factor: 21.596

10.  Insomnia as a Moderator of Response to Time in Bed Restriction for Augmenting Antidepressant Treatment: A Preliminary Investigation.

Authors:  Leslie M Swanson; Edward D Huntley; Holli Bertram; Ann Mooney; Richard Dopp; Robert Hoffmann; Roseanne Armitage; J Todd Arnedt
Journal:  Behav Sleep Med       Date:  2016-08-05       Impact factor: 2.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.